TP53 and lung carcinoma: Such DNA spreading assays were performed in K562, H1299 lung carcinoma, U2OS osteosarcoma, and primary human CD34+ hematopoietic stem and progenitor cells after transient elimination or restoration of p53, whereby care was taken that expression levels did not exceed endogenous p53 levels [36].